Pure Global

AMYLASE ISOENZYME - ANVISA Registration 10300390301

Access comprehensive regulatory information for AMYLASE ISOENZYME in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10300390301 and manufactured by DIALAB GMBH. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., IN VITRO DIAGNOSTICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10300390301
Registration Details
ANVISA Registration Number: 10300390301
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

ALFA- AMILASE CNP-G3 DIALAB
Risk Class II

Registration Details

10300390301

25351774695201848

00904728000148

Company Information

DIALAB GMBH
Austria
PT: รUSTRIA

Dates and Status

Dec 17, 2018

VIGENTE

09/18/2025 19:00:01